Cincinnati-based Xavier Health launched its Xavier Health Artificial Intelligence Initiative to research predictive and prescriptive insights for the pharmaceutical and medical device industry.
The initiative, rolled out in partnership with IBM Watson Health, was introduced at Xavier Health's annual pharmaceutical conference in March. The program's core mission is to help the U.S. Food and Drug Administration and other industry stakeholders improve patient safety and business operations across quality, regulatory affairs and supply chain operations.
To discuss these issues, the Xavier Health Artificial Intelligence Initiative will host an AI summit Aug. 24 and Aug. 25.